This review focuses on the role of PI3K/Akt signaling in IPF pathogenesis, its intersection with inflammation and fibrosis, and emerging therapeutic approaches targeting molecules along this pathway. The gene discussed is AKT1; the disease is idiopathic pulmonary fibrosis.